Cargando…

Evaluation of residue variability in a conformation‐specific context and during evolutionary sequence reconstruction narrows drug resistance selection in Abl1 tyrosine kinase

Diseases with readily available therapies may eventually prevail against the specific treatment by the acquisition of resistance. The constitutively active Abl1 tyrosine kinase known to cause chronic myeloid leukemia is an example, where patients may experience relapse after small inhibitor drug tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Otsuka, Felipe A. M., Bjelic, Sinisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202545/
https://www.ncbi.nlm.nih.gov/pubmed/35762721
http://dx.doi.org/10.1002/pro.4354